Delivery Order SPE2DB22D1017-SPE2DB25FF0CA

Award Date 11/27/24
Potential Completion Date 12/19/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with an ultimate completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award valued at $1,129.80 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,135.77, is for the procurement of Pfizer COVID-19 vaccines with a 0.9mL dosage for the 2024-2025 period, under a Firm Fixed Price contract. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.70 firm-fixed-price contract is for the delivery of Pfizer COVID-19 vaccine doses, with a performance period from June 2024 to June 2025. This award is not designated as a set-aside contract. The contract is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,355.84 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, for the supply of 0.9 ml COVID-19 vaccines from Pfizer for the period of March 2023 to March 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued up to $999,999,999.00, to provide a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.15 Firm Fixed Price delivery order is for the supply of Pfizer COVID-19 vaccines and related medical products from 2024 to 2025, with a potential performance period of up to 4 years. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccine doses, with a ceiling value of $3,141.40 and a period of performance from April 2024 to April 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed price contract is for the delivery of Pfizer COVID-19 vaccine doses from 2024 to 2025, with a period of performance ending on November 29, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the delivery of Pfizer COVID-19 vaccine doses between 2024-2025, under the Emergency Use Authorization (EUA) program. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award, valued at $1,092.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF0CA
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,259.62, is for the delivery of 0.9 mL doses of the Pfizer COVID-19 vaccine, with a period of performance from November 2024 to December 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen plays a critical role in supplying essential medical products to government agencies.

Generated 2/26/25, 9:46 AM